Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04358029 · ClinicalTrials.gov registry record

Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)

A clinical trial, sponsored by Vivek Reddy.

Completed
Registry status
4,000
Enrollment target

NCT04358029 is a clinical trial that has completed, run by Vivek Reddy. The registered enrollment target is 4,000 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04358029 has completed, sponsored by Vivek Reddy.

COMPLETED
Registry status
4,000 participants
Enrollment target

Study Summary

The objective of the study is to estimate the frequency of cardiac arrhythmias and characterize the mode of death in patients with coronavirus disease (SARS-CoV-2; COVID-19). The study will also evaluate the long term cardiac outcomes in patients previously diagnosed with COVID-19. This is a single-center, retrospective/ prospective registry enrolling all COVID-19 positive patients at Mount Sinai Hospital. Cohort 1: Retrospective chart review: 1. Patients who have been diagnosed with COVID-19 infection at Mount Sinai Hospital will be included. 2. A cohort of 1000 influenza patients will also be evaluated for purpose of comparison. Cohort 2: Prospective data collection of 100 patients who: 1. Were hospitalized for COVID-19 and who had an abnormal echocardiogram during hospitalization. 2. A matched cohort (for age, gender, troponin level, and days since hospital discharge) who did not have abnormalities on their echocardiograms (or who did not undergo echocardiogram) to ascertain that in this unusual disease, subjects did not develop echo abnormalities following hospital discharge.

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2020-04-09
Est. Completion 2023-04-01

Sponsor

Vivek Reddy

20 total trials

What the Registry Record Tells You About NCT04358029

The ClinicalTrials.gov registry entry for NCT04358029 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04358029 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04358029 about?

NCT04358029 is a clinical study titled "Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)". The objective of the study is to estimate the frequency of cardiac arrhythmias and characterize the mode of death in patients with coronavirus disease (SARS-CoV-2; COVID-19). The study will also evaluate the long term cardiac outcomes in patients previously diagnosed with COVID-19. This is a single...

What is the current status of trial NCT04358029?

This trial is currently completed. The enrollment target is 4,000 participants. The study started on 2020-04-09. Estimated completion is 2023-04-01.

Who is sponsoring clinical trial NCT04358029?

This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.